According to Mirati Therapeutics's latest financial reports the company has $0.97 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $1.08 B | -27.32% |
2021-12-31 | $1.49 B | 7.28% |
2020-12-31 | $1.39 B | 234.92% |
2019-12-31 | $0.41 B | 86.3% |
2018-12-31 | $0.22 B | 47.7% |
2017-12-31 | $0.15 B | 165.87% |
2016-12-31 | $56.73 M | -53.62% |
2015-12-31 | $0.12 B | 317.46% |
2014-12-31 | $29.3 M | -52.79% |
2013-12-31 | $62.07 M | 67.83% |
2012-12-31 | $36.98 M | 30.53% |
2011-12-31 | $28.33 M | 284.97% |
2010-12-31 | $7.35 M | -55.86% |
2009-12-31 | $16.67 M | -47.44% |
2008-12-31 | $31.72 M | -48.27% |
2007-12-31 | $61.32 M | 8.67% |
2006-12-31 | $56.43 M | 149.93% |
2005-12-31 | $22.58 M | -34.46% |
2004-12-31 | $34.45 M | 44.99% |
2003-12-31 | $23.76 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
TravelCenters of America TA | $0.38 B | -60.48% | ๐บ๐ธ USA |
Nymox Pharmaceutical NYMX | $0.13 M | -99.99% | Bahamas |